Clinical Trial Results TV
Main Menu
Home Page
Member Area
Browse all videos
Series
Duke Clinical Medicine
Cath Lab
ACS
Endocrinology
Gastroenterology
Nephrology
Heart Failure
SCAI TV
Categories
Antiplatelets
Antithrombins
Aortic Disease
Behind The Science
Biomarkers
CABG
CHF
CT Angio
Cardiac MRI
Clinical Cases
Congenital
DVT / PE
Diabetes
ECG, EKG, Holter
ECHO
EP
ETT / Nuclear Imaging
Fellows' Training
Genetics
HTN
Health economics QOL
Hospital Administration
International
Lipid Lowering
Lower extremity Dz
Lytics
Non Atherosclerotic Arterial Dz
PAD
PCI / Devices
Pathophysiology
Patient Education
Pericardium
Private Practice
Public Health
Pulm. Art. HTN
ST Elevation MI
Stable Angina
Stem Cell Tx
Stroke
Trial / Study
UA / NSTEMI
Valvular Heart Dz
Vlogs
Womens' Health
Dr Gibson discusses Rosiglitazone and MI, decline in DES used after COURAGE
Dr Gibson discusses Rosiglitazone and the risk of MI, and the decline in DES (Drug Eluting
Stents) used after COURAGE.
[
Download video
]
Video Statistics
5 out of 5
click a star to vote
This submission has received
1
total votes.
These statistics are updated nightly. The last update ran on
11-23-2024 EST
at
1 am
.
Additional Files
Filename
File Description
Action
No additional files available
Comments [
login to comment
]
No comments have been submitted
clinicaltrialresults.org